Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture.

Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.] Continue reading ->

Image Credits: South Centre.

Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is one of two. An interview with Carlos Correa will follow.] Continue reading ->

Image Credits: Alex Bego.

WASHINGTON, DC — Recently named director of the US Centers for Disease Control and Prevention (CDC) Robert Redfield told a gathering of global health experts this week that the most critical investment that can be made is in global health security, with the recent fast response to the Ebola outbreak in the Democratic Republic of the Congo setting the example.  Continue reading ->

Image Credits: William New.

By David Branigan for Health Policy Watch

Member states of the United Nations highlighted progress on combatting AIDS at a 12 June meeting of the General Assembly, with AIDS-related deaths reduced “from 1.5 million in 2010 to 1 million in 2016,” according to a UN report citing UNAIDS data. But the report found progress toward eliminating the disease to be uneven, and provided recommendations to address gaps and challenges. Continue reading ->

Following the South African government’s recent approval of a new intellectual property policy that includes elements aimed at preserving access to medical products that are increasing in popularity among developing countries, the research-based pharmaceutical industry had a few general comments. The message: the policy incorporates some of their concerns but is wrong on “evergreening” patents, and could harm industry, which is “the goose that lays the golden egg.” Continue reading ->